9. Masaoka T, Takaku F, Kato S, Moriyama Y, Kodera Y, Kanamaru A, Shimosaka A, Shibata H, 
Nakamura H: Recombinant human granulocyte colony-stimulating factor in allogeneic bone 
marrow transplantation. Exp Hematol 17: 1047-1050, 1989. 
10. Taylor K, Spitzer G, Jagannath S, Dicke K, Souza L: Phase II study of recombinant human 
granulocyte colony-stimulating factor (rhG-CSF) in Hodgkin’s disease after high-dose 
chemotherapy with ABMT. Blood 72(Suppl.l): 135a, 1988. (abstr.) 
11. Oppenheim JJ, Neta R, Tiberghien P, Gress R, Kenny JL, Longo DL: Interleukin- 1 enhances 
survival of lethally irradiated mice treated with allogeneic bone marrow cells. Blood 74: 
2257-2263, 1989. 
12. Sandoz Pharmaceuticals Corporation Research Data. 
13. Monroy RL, Davis JA, Donahue RE, MacVittie TJ: Collection of enriched PBSC’s 
from primates treated with IL1 and IL3 in vitro. (Abstract) Blood 74: 75a, 1989. 
14. Donahue RE, Seehra J, Metzger M, Lefebvre D, Rock B, Carbone S, Nathan DG, Gamick M, 
Sehgal PK, Laston D, LaVallie E, McCoy J, Schendel PF, Norton C, Turner K, Yang Y-C, Clark 
SC: Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. 
Science 241: 1820-1823, 1988. 
15. Krumwieh D, Seiler FR: In vivo effects of recombinant colony stimulating factors on 
hematopoiesis in cynomolgus monkeys. Transplant Proc 21: 2964-2967, 1989. 
16. Mayer P, Valent P, Schmidt G, Liehl E, Bettelheim P: The in vivo effects of recombinant human 
interleukin-3: Demonstration of basophil differentiation factor, histamine-producing activity, and 
priming of GM-CSF-responsive progenitors in nonhuman primates. Blood 74: 613-621, 1989. 
17. Personal communication, Lee Nadler, Dana Farber, Boston, MA. 
18. Gianni AM, Siena S, Bregni M, Tarella C, Stem AC, Pileri A, Bonadonna G: 
Granulocyte-macrophage .colony-stimulating factor to harvest circulating haemopoietic stem cells 
for autotransplantation. Lancet ii: 580-585, 1989. 
19. Peters WP, Kurtzberg I, Kirkpatrick G, Atwater S, Gilbert C, Borowitz M, Shpall E, Jones R, 
Ross M Affronti M, Coniglio D, Mathias B, Odette D. GM-CSF primed peripheral blood 
progenitor cells (PBPC) coupled with autologous bone marrow transplantation (ABMT) will 
eliminate absolute leukopenia following high dose chemotherapy (HDC) Blood 74: 50a 
(Abstract). 
20. Gianni AM, Bregni M, Siena S, Villa S, Sciorelli GA, Ravagnani F, Pellegris G, Bonadonna G: 
Rapid and complete hemopoietic reconstitution following combined transplantation of 
autologous blood and bone marrow cells. A changing role for high dose chemo-radiotherapy? 
Hematol Oncol 7: 139-148, 1989. 
21. Gianni AM, Siena S, Bregni M, Tarella C, Ferrero D, Sciorelli GA, Bonadonna G: Very rapid 
and complete haemopoietic reconstitution following myeloablative treatments: The role of 
circulating stem cells harvested after high-dose cyclophosphamide and GM-CSF. In: Dicke K, 
Spitzer G, Jagannath S, Evinger-Hodges MJ, (eds.), Autologous Bone Marrow Transplantation, 
p. 723-731, 1990. 
22. Ventura GJ, Hester JP, Spitzer G, Dunphy FR, Wallerstein R, LeMaistre CF, Gutterman JU, 
Deisseroth AB: Use of GMCSF mobilized peripheral blood stem cells (PBSC) for hematopoietic 
recovery after high dose chemotherapy (HDC) and autologous bone marrow transplantation 
(ABMT). Blood 74: 425a, 1989. (abstr.) 
23. Reiffers J, Bernard P, David B, Vezon G, Sarrat A, Marit G, Moulinier J, Broustet A: 
Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with 
acute leukemia. Exp Hematol 14: 312-315, 1986. 
24. Bell AJ, Hamblin TJ, Oscier DG: Peripheral blood stem cell autografting. Hematol Oncol 5: 
45-55, 1987. 
[352] 
Recombinant DNA Research, Volume 16 
